A Short Update on the Use of Monoclonal Antibodies in COVID-19-Reference-Cited by-同舟云学术

A Short Update on the Use of Monoclonal Antibodies in COVID-19

Published:2024-03-05 Issue:2 Volume:26 Page:
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Vitiello Antonio^ORCID,Sabbatucci Michela,Ponzo Annarita,Salzano Antonio,Zovi Andrea

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1208/s12248-024-00904-y.pdf

Reference25 articles.

1. Vitiello A, Zovi A, Rezza G. New emerging SARS-CoV-2 variants and antiviral agents. Drug Resist Updat. 2023;26(70):100986. https://doi.org/10.1016/j.drup.2023.100986. (SARS-CoV-2 variants of concern as of 24 August 2023 (europa.eu) access 26 August 2023).

2. RECOVERY Collaborative Group. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022;399(10325):665–76. https://doi.org/10.1016/S0140-6736(22)00163-5.

3. Sabbatucci M, Vitiello A, Clemente S, Zovi A, Boccellino M, Ferrara F, et al. Omicron variant evolution on vaccines and monoclonal antibodies. Inflammopharmacology. 2023;19:1–10. https://doi.org/10.1007/s10787-023-01253-6.

4. European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 24 August 2023. [Internet] https://www.ecdc.europa.eu/en/covid-19/variants-concern. Accessed 26 Aug 2023.

5. Ferrara F, Zovi A, Masi M, Langella R, Trama U, Boccellino M, et al. Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(7):1583–9. https://doi.org/10.1007/s00210-023-02417-5.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens;Pharmaceutical Research;2024-08